Keyphrases
Rodents
100%
Phosphodiesterase 4 Inhibitor
100%
Roflumilast
100%
Rolipram
50%
Phosphodiesterase-4 (PDE4)
37%
Cognition Enhancer
25%
Memory Enhancing
25%
Anesthesia
12%
Cognitive Function
12%
Cognitive Performance
12%
Cognitive Deficits
12%
Chronic Obstructive Pulmonary Disease
12%
Monkey
12%
Pharmacological Inhibitors
12%
Surrogate Marker
12%
Memory Deficits
12%
Cognition Enhancement
12%
Object Location Task
12%
Scopolamine
12%
Donepezil
12%
FDA-approved Drugs
12%
Second Messenger
12%
Object Recognition Memory
12%
Ketamine
12%
Muscarinic Antagonists
12%
Receptor Antagonism
12%
Y-maze
12%
Hydrolytic Enzymes
12%
α2-adrenergic Receptor
12%
Xylazine
12%
INIS
doses
100%
rodents
100%
phosphodiesterases
100%
inhibition
50%
receptors
33%
comparative evaluations
33%
side effects
33%
diseases
16%
rats
16%
competition
16%
availability
16%
anesthesia
16%
brain
16%
mice
16%
recovery
16%
enzymes
16%
performance
16%
monkeys
16%
adrenergics
16%
Neuroscience
Phosphodiesterase-4 Inhibitor
100%
Roflumilast
100%
Emetic Agent
100%
Rolipram
50%
Phosphodiesterase
37%
Enhancer Region
25%
Second Messenger System
12%
Recognition Memory
12%
Cognitive Function
12%
Chronic Obstructive Pulmonary Disease
12%
Cognitive Disorders
12%
Cyclic Adenosine Monophosphate
12%
Scopolamine
12%
Alpha-2 Adrenergic Receptor
12%
Donepezil
12%
Ketamine
12%
Muscarinic Antagonist
12%
Xylazine
12%
Hydrolase
12%